NK1.1+CD8 T cells from OT-I mice performed rapid and vigorous killing of tumor cells, while the NK1.1− cytotoxic T lymphocyte (CTL) population failed to exhibit potent antitumor effects, indicative of the more efficient tumoricidal effects of CD8+NKT-like cells [17]. This evidence concerns the gene CD8A and neoplasm.